Jointech-Med

Company Overview

Snapshot

Founded in May 2008 by Natanja Slager and Nir Altschuler, Jointech-Med operates with 1–10 employees. The company is currently in a non-active status as of February 2010.

Business overview

Jointech-Med is focused on developing an intra-articular device designed to reduce intra-articular pressure and continuously evacuate inflammatory mediators from painful, effused knees. This technology aims to alleviate pain, improve quality of life, and decelerate disease progression in patients suffering from conditions like osteoarthritis and rheumatoid arthritis, particularly targeting those in their fifth or sixth decade who are considered too young for total knee replacement surgery. The company operates within the Health Tech & Life Sciences sector, specifically in Medical Devices and Medical Treatment & Therapeutics, serving healthcare providers.

Company Intelligence Q&A

What is Jointech-Med's primary focus?

Jointech-Med's main focus is on patients suffering from painful knee arthritis with effusion, particularly those in their fifth or sixth decade who are not yet candidates for knee replacement surgery.

What is the core technology developed by Jointech-Med?

Jointech-Med is developing an intra-articular device designed to reduce intra-articular pressure and continuously evacuate inflammatory mediators from affected knee joints.

Who are the founders of Jointech-Med?

Jointech-Med was founded by Natanja Slager and Nir Altschuler.

When was Jointech-Med founded?

Jointech-Med was founded in May 2008.

What is the current operational status of Jointech-Med?

Jointech-Med is currently in a non-active status as of February 2010.